GeGe Clements profile photo

GeGe Clements, B.A.

  • Center for Cancer Research
  • National Cancer Institute


GeGe Clements is a post-baccalaureate researcher working closely with Dr. Yanlin Yu. Her research focuses on the signaling pathways responsible for acquired resistance to conventional drug therapies during the progression of metastatic melanoma. Her major goal remains to provide recommendations for new drugs that will reduce the metastatic burden and improve therapeutic cancer outcomes.

Areas of Expertise

1) metastatic melanoma, 2) drug therapy resistance, 3) tumor metastasis, and 4) FGFR signaling pathway